Alfresa Corporation is a Tokyo-based Japanese corporate strategic investor tied to pharmaceutical distribution and healthcare supply chain operations. It is relevant for later-stage life sciences, biotechnology, pharmaceuticals, HealthTech and medical devices companies seeking strategic alignment around commercialization, distribution or market access in Japan.